Acumen Pharmaceuticals, Inc. Share Price
NASDAQ: ABOS | Micro CapAcumen Pharmaceuticals, Inc. Stock Performance
Open $2.98 | Prev. Close $3.04 | Circuit Range N/A |
Day Range $2.89 - $2.99 | Year Range $1.22 - $3.60 | Volume 13,481 |
Average Traded $2.92 |
Acumen Pharmaceuticals, Inc. Share Price Today
As of 30 August 2026, Acumen Pharmaceuticals, Inc.'s share price is $2.91. The stock opened at $2.98, compared to its previous close of $3.04. During today's trading session, Acumen Pharmaceuticals, Inc.'s share price traded between $2.89 and $2.99, with an average price of $2.94. Over the past 52 weeks, the stock has recorded a high of $3.60 and a low of $1.22. In terms of performance, Acumen Pharmaceuticals, Inc.'s share price has declined by 8.06% over the last six months and is up 115.56% on a year-on-year basis.
Acumen Pharmaceuticals, Inc. Share Price Chart
Acumen Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap $176.23M | PE Ratio (TTM) -1.46 | Dividend Yield N/A |
EPS (TTM) $-2.00 | Revenue (TTM) N/A | Return On Equity (TTM) -172.28% |
Profit Margin N/A | Debt to Equity 0.43 | Quarterly Earnings Growth YoY 11.13% |
Acumen Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Acumen Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.
Acumen Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $2.13 | $3.04 | +41.40% |
Jul 2026 | $2.59 | $2.15 | -19.17% |
Jun 2026 | $2.60 | $2.66 | +1.92% |
May 2026 | $2.38 | $2.61 | +9.21% |
Apr 2026 | $2.46 | $2.39 | +1.49% |
Mar 2026 | $3.07 | $2.35 | -25.59% |
Feb 2026 | $2.54 | $3.17 | +21.97% |
Jan 2026 | $2.09 | $2.60 | +24.46% |
Dec 2025 | $1.86 | $2.08 | +10.61% |
Nov 2025 | $2.17 | $1.89 | -13.33% |
Oct 2025 | $1.77 | $2.17 | +27.19% |
Sep 2025 | $1.34 | $1.71 | +26.67% |
ABOS Share Price FAQs
What is Acumen Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of Acumen Pharmaceuticals, Inc. stock?
What is ABOS's market capitalisation today?
What is ABOS's net income for the last quarter?
What is the 5 year returns of ABOS?
What is the high & low stock price of ABOS today?
Can I buy ABOS shares in India?